These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 37502435)

  • 61. Hepatic encephalopathy - recent advances in treatment and diagnosis.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):225-235. PubMed ID: 36843291
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Disaccharides in the treatment of hepatic encephalopathy.
    Sharma P; Sharma BC
    Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy.
    Rai R; Ahuja CK; Agrawal S; Kalra N; Duseja A; Khandelwal N; Chawla Y; Dhiman RK
    Clin Transl Gastroenterol; 2015 Sep; 6(9):e111. PubMed ID: 26378384
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Minimal hepatic encephalopathy.
    Stinton LM; Jayakumar S
    Can J Gastroenterol; 2013 Oct; 27(10):572-4. PubMed ID: 24106728
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Minimal hepatic encephalopathy: A review.
    Nardone R; Taylor AC; Höller Y; Brigo F; Lochner P; Trinka E
    Neurosci Res; 2016 Oct; 111():1-12. PubMed ID: 27153746
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.
    Mousa N; Abdel-Razik A; Zaher A; Hamed M; Shiha G; Effat N; Elbaz S; Elhelaly R; Hafez M; El-Wakeel N; Eldars W
    Therap Adv Gastroenterol; 2016 Sep; 9(5):684-91. PubMed ID: 27582881
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Minimal hepatic encephalopathy.
    Sharma P
    J Assoc Physicians India; 2009 Nov; 57():760-3. PubMed ID: 20329443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intravenous versus oral 'L-ornithine-L-aspartate' in overt hepatic encephalopathy: a randomized comparative study.
    Jhajharia A; Singh S; Jana S; Ashdhir P; Nijhawan S
    Sci Rep; 2024 May; 14(1):11862. PubMed ID: 38789596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Advances in the evaluation and management of minimal hepatic encephalopathy.
    Montgomery JY; Bajaj JS
    Curr Gastroenterol Rep; 2011 Feb; 13(1):26-33. PubMed ID: 20924726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Management options for minimal hepatic encephalopathy.
    Bajaj JS
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.
    Zhang Y; Feng Y; Cao B; Tian Q
    Int J Clin Exp Med; 2015; 8(2):2954-7. PubMed ID: 25932262
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011451. PubMed ID: 30610762
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis.
    Bajaj JS; Pinkerton SD; Sanyal AJ; Heuman DM
    Hepatology; 2012 Apr; 55(4):1164-71. PubMed ID: 22135042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combination therapy for the treatment and prevention of hepatic encephalopathy.
    Mohammad RA; Regal RE; Alaniz C
    Ann Pharmacother; 2012 Nov; 46(11):1559-63. PubMed ID: 23092866
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Probiotic yogurt for the treatment of minimal hepatic encephalopathy.
    Bajaj JS; Saeian K; Christensen KM; Hafeezullah M; Varma RR; Franco J; Pleuss JA; Krakower G; Hoffmann RG; Binion DG
    Am J Gastroenterol; 2008 Jul; 103(7):1707-15. PubMed ID: 18691193
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.
    Varakanahalli S; Sharma BC; Srivastava S; Sachdeva S; Dahale AS
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):951-958. PubMed ID: 29727385
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lactulose Management of Minimal Hepatic Encephalopathy: A Systematic Review.
    Zucker DM; Redulla R
    Gastroenterol Nurs; 2019; 42(1):84-94. PubMed ID: 30688711
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.
    El-Karaksy HM; Afifi O; Bakry A; Kader AA; Saber N
    World J Pediatr; 2017 Feb; 13(1):70-75. PubMed ID: 27878780
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy.
    Direkze S; Jalan R
    Dig Dis; 2015; 33(4):562-9. PubMed ID: 26159274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.